Leading pharmaceutical, biotechnology and medical device companies come to us for EU and Belgian advisory and transactional legal support on their national and cross-border projects.

Our multi-disciplinary team combines life sciences and healthcare, commercial, transactional, data privacy, intellectual property, competition and regulatory expertise with experience of new and emerging technologies, such as the integration of artificial intelligence into products and services and the use of patient data in digital healthcare.

Our up-to-the-minute understanding of the fast-evolving life sciences industry is reflected in our advice.

Working closely with your legal and business teams, we are able to meet all your needs, from advice on regulatory risk and compliance strategy, to representing you in antitrust investigations at EU and national level and in complex patent litigation.

We supplement our in-house capabilities through an extensive network of specialist law firms in other Member States, where needed, providing you a pan-European one-stop shop solution.

Particular areas of expertise include registration, early market access schemes, pricing and reimbursement strategies, pre- and post-marketing regulations, clinical trials, data exclusivity, orphan medicines, advertising and promotion, distribution, public procurement bids, patient support schemes, industry-wide sustainability initiatives, advanced therapies, life cycle management, dispute resolution and novel issues related to the use of cloud-based services.

As the industry adapts to meet new imperatives, we can help you meet competitive pressures head-on.

VBB’s expertise in the pharma sector sets it apart, making it my go-to firm for regulatory and antitrust matters throughout Europe.
Client, Legal 500 2025, Industry focus: Healthcare and life sciences